Patent · US Active

Inhibitors of hepatitis C virus replication

US7781474B2 · kind B2 · utility

6Cited by

70References

13Claims

0Family size

Assignee

INTERMUNE, INC. · US

Inventors

Scott D. Seiwert · Pacifica, US
Leonid Beigelman · San Mateo, US
Lawrence M. Blatt · San Francisco, US
Timothy Kercher · Longmont, US
April L. Kennedy · Denver, US
Steven W. Andrews · Longmont, US

Key dates

Filing date	Jul 5, 2007
Grant date	Aug 24, 2010
Priority date	—
Expiry date	Dec 26, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The embodiments provide compounds of the general Formula I, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula II, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments provide compounds of the general Formula III, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.